In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Relmada Therapeutics Inc’s stock clocked out at $4.06, up 0.50% from its previous closing price of $4.04. In other words, the price has increased by $0.50 from its previous closing price. On the day, 1.52 million shares were traded. RLMD stock price reached its highest trading level at $4.25 during the session, while it also had its lowest trading level at $3.7.
Ratios:
To gain a deeper understanding of RLMD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.86 and its Current Ratio is at 2.86. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 05, 2024, Mizuho Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $23 to $1.
Jefferies Upgraded its Hold to Buy on September 17, 2024, whereas the target price for the stock was revised from $3.50 to $13.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 05 ’25 when Shenouda Maged bought 500,000 shares for $2.20 per share. The transaction valued at 1,100,000 led to the insider holds 788,335 shares of the business.
Ence Chuck bought 136,000 shares of RLMD for $299,200 on Nov 05 ’25. The CAO and COO now owns 403,931 shares after completing the transaction at $2.20 per share. On Nov 05 ’25, another insider, TRAVERSA SERGIO, who serves as the Chief Executive Officer of the company, bought 272,500 shares for $2.20 each. As a result, the insider paid 599,500 and bolstered with 1,272,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLMD now has a Market Capitalization of 297734496 and an Enterprise Value of 283847968.
Stock Price History:
The Beta on a monthly basis for RLMD is 0.80, which has changed by 7.9777775 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, RLMD has reached a high of $5.12, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is 44.01%, while the 200-Day Moving Average is calculated to be 247.80%.
Shares Statistics:
It appears that RLMD traded 1.02M shares on average per day over the past three months and 1047770 shares per day over the past ten days. A total of 73.33M shares are outstanding, with a floating share count of 50.90M. Insiders hold about 30.59% of the company’s shares, while institutions hold 14.57% stake in the company. Shares short for RLMD as of 1763078400 were 946511 with a Short Ratio of 0.93, compared to 1760486400 on 562426. Therefore, it implies a Short% of Shares Outstanding of 946511 and a Short% of Float of 1.2999999.
